A randomized trial of cilostazol versus ticlopidine for anti-platelet therapy after coronary artery stenting for prevention of restenosis
- VernacularTitle:西洛他唑与噻氯匹定预防冠心病支架置入术后冠状动脉再狭窄的效果对比
- Author:
Bin HONG
;
Juying QIAN
;
Bing FAN
- Publication Type:Journal Article
- Keywords:
Angioplasty,transluminal,percutaneous coronary;
Platelet aggregation inhibitors;
Cilostazol;
Ticolopidene
- From:
Chinese Journal of Interventional Cardiology
1993;0(03):-
- CountryChina
- Language:Chinese
-
Abstract:
0.05).Conclusion Aspirin plus cilostazol showed comparable antithrombotic effect as aspirin plus ticlopidine after elective coronary stenting and may serve as an alternative treatment for patients intolerable to ticlopidine.
